Medical Decision Making and Model Choice

Medical Decision Making and Model Choice

In this video, Jeremy Goldhaber-Fiebert discusses choosing a model type to evaluate a medical decision, emphasizing the importance of considering the underlying process.

In Brief

 

Professor of Health Policy Jeremy Goldhaber-Fiebert, PhD, discusses the rationale of using state-transition models, dynamic modeling, discrete event simulation, agent-based modeling, and Markov decision process models. Subsequently, the discussion moves to recent developments in calibration and validation with reflections on Bayesian calibration, meta-models, and accounting for correlation between input parameters.

This video is part of a series developed by Professor of Health Decision Sciences Myriam Hunink, MD, PhD, during an immersion residency with the Media Hub at the Center for Health Decision Science at the Harvard T.H. Chan School of Public Health. The interview was facilitated by Hunink during the Society for Medical Decision Making (SMDM) 46th annual meeting held in Boston, Massachusetts. 

 

Jeremy Goldhaber-Fiebert & Myriam Hunink

 

Read More

A photo of a blood pressure gauge
News

Post COVID-19 Hypertension: A Longitudinal Study of 40,000 Incarcerated Adults

SHP researchers and colleagues at the California Correctional Health Care Services find that COVID-19 is associated with significant increases in hypertension incidence in the large, racially and ethnically diverse prison population.
Post COVID-19 Hypertension: A Longitudinal Study of 40,000 Incarcerated Adults
Barbed wire and community
News

AI Outperforms Traditional Methods in Controlling Disease Spread Between Prisons and Communities

SHP researchers built a model to test whether AI could beat traditional methods to stop disease spread between prisons and nearby communities. The verdict was clear.
AI Outperforms Traditional Methods in Controlling Disease Spread Between Prisons and Communities
An illustration of a heart
News

Less Invasive Heart Procedure Proves Just as Effective—And Less Expensive

Previous studies found coronary artery bypass grafting (CABG) to be cost-effective compared with percutaneous coronary intervention (PCI), but new research led by SHP's Mark Hlatky shows their comparative effectiveness and economic outcomes may have changed.
Less Invasive Heart Procedure Proves Just as Effective—And Less Expensive